Patent Application
Utility
PCT National Stage
App. No. 12/740,786
· Confirmation No. 1064
USE OF 3, 11B-CIS-DIHYDROTETRABENAZINE IN THE TREATMENT OF MULTIPLE SCLEROSIS AND AUTOIMMUNE MYELITIS
Inventor:
Andrew John Duffield
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2013-04-11 | ABN |
Abandonment | 2 | View | |
| 2012-10-04 | CTRS |
Requirement for Restriction/Election | 9 | View | |
| 2011-02-17 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2010-11-08 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2010-11-08 | M903 |
Notice of Designated Office (DO) / Elected Office (EO) Acceptance Mailed | 2 | View | |
| 2010-11-03 | PA.. |
Power of Attorney | 1 | View | |
| 2010-11-03 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2010-11-03 | TRAN.LET |
Transmittal Letter | 1 | View | |
| 2010-11-03 | R3.73 |
Assignee showing of ownership per 37 CFR 3.73 | 1 | View | |
| 2010-10-25 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2010-10-25 | OATH |
Oath or Declaration filed | 3 | View | |
| 2010-10-25 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2010-10-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2010-10-25 | TRAN.LET |
Transmittal Letter | 1 | View | |
| 2010-09-14 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2010-09-14 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2010-09-13 | M905 |
Notice of DO/EO Missing Requirements Mailed | 2 | View | |
| 2010-04-30 | TRNA |
Transmittal of New Application | 1 | View | |
| 2010-04-30 | TRNA |
Transmittal of New Application | 3 | View | |
| 2010-04-30 | ADS |
Application Data Sheet | 3 | View | |
| 2010-04-30 | A.PE |
Preliminary Amendment | 1 | View | |
| 2010-04-30 | SPEC |
Specification | 1 | View | |
| 2010-04-30 | CLM |
Claims | 7 | View | |
| 2010-04-30 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2010-04-30 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2010-04-30 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 1 | View | |
| 2010-04-30 | 371P |
Documents submitted with 371 (National Stage) Applications | 49 | View | |
| 2010-04-30 | 371P |
Documents submitted with 371 (National Stage) Applications | 3 | View | |
| 2010-04-30 | FOR |
Foreign Reference | 71 | View | |
| 2010-04-30 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2010-04-30 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2010-04-30 | ABST |
Abstract | 1 | View | |
| 2010-04-30 | SPEC |
Specification | 42 | View | |
| 2010-04-30 | CLM |
Claims | 4 | View | |
| 2010-04-30 | DRW |
Drawings-only black and white line drawings | 2 | View | |
| 2010-04-30 | FRPR |
Certified Copy of Foreign Priority Application | 53 | View | |
| 2010-04-30 | FRPR |
Certified Copy of Foreign Priority Application | 53 | View | |
| 2010-04-30 | ABST |
Abstract | 1 | View | |
| 2010-04-30 | SPEC |
Specification | 42 | View | |
| 2010-04-30 | CLM |
Claims | 4 | View | |
| 2010-04-30 | DRW |
Drawings-only black and white line drawings | 2 | View | |
| 2010-04-30 | WFEE |
Fee Worksheet (SB06) | 1 | View |
Inventors
Andrew John Duffield
Hertfordshire, UNITED KINGDOM
Attorneys & Agents of Record
Classification
USPC
514/294
A61K31/4745
Prosecution
- Examiner
- MCMILLIAN, KARA RENITA
- Art Unit
- 1627
- Customer No.
- 21186
- Docket No.
- 3063.024US1
- Confirmation No.
- 1064
Foreign Priority
0721669.0
·
2007-11-02
·
UNITED KINGDOM
Publication
- Pub. No.
- US20110039877A1
- Pub. Date
- 2011-02-17
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
NOTICE OF SUCCESSION OF AGENCY
Recorded 2015-01-09
CHANGE OF NAME
Recorded 2011-04-01
PATENT SECURITY RELEASE AGREEMENT
Recorded 2011-03-14
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2010-10-25
SECURITY AGREEMENT
Recorded 2010-10-04
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 12/740,786
- Filed
- 2010-10-25
- Effective Filing
- 2010-04-30
- Pub. No.
- US20110039877A1
- Examiner
- MCMILLIAN, KARA RENITA
- Art Unit
- 1627
External Links